Anticoagulated Patient Needing Urgent Extraction With Signs of Retained Root

This is an urgent infection, not elective surgery, so the priority is source control. For apixaban, routine preoperative discontinuation is not required for most dentoalveolar procedures; the drug has a ~12-hour half-life and can often be continued with local hemostatic measures. However, because he has moderate renal impairment (CrCl 52 mL/min), the elimination half-life is prolonged, and if the procedure is delayed more than 24 hours, coordinate with his cardiologist or primary care physician rather than stopping on your own.

Key reasoning points:

• Do not stop the anticoagulant solely because of the extraction; the thrombotic risk of stopping in atrial fibrillation must be weighed against bleeding risk.
• Use local measures: atraumatic technique, sutures, oxidized cellulose or gelatin sponge, and pressure. Tranexamic acid mouthwash (4.8%) can be used postoperatively.
• Check hemoglobin and platelet count if bleeding is anticipated; do not rely on INR for apixaban.
• If significant bleeding occurs, reversal with andexanet alfa or prothrombin complex concentrate is a hospital-level decision, not an office one.
• Document the risk-benefit discussion and involve the prescribing physician.

The patient has a fluctuant buccal swelling with trismus and a retained root, so incision and drainage plus removal of the source (the retained root) is indicated. Antibiotics alone are inadequate because the source is not controlled. Culture and sensitivity should be obtained if pus is available, especially given failure of amoxicillin-clavulanate.

Escalate to hospital admission if any of the following are present:

• Signs of systemic toxicity (fever, tachycardia, hypotension, malaise)
• Dysphagia, odynophagia, drooling, voice change, or airway compromise
• Spread to fascial spaces (submandibular, sublingual, pterygomandibular, lateral pharyngeal)
• Trismus severe enough to prevent adequate access
• Uncontrolled diabetes or immunocompromise with rapid progression
• Inability to obtain hemostasis or need for reversal agents

In this case, absence of fever and lack of airway symptoms support outpatient management, but the patient should be reassessed within 24-48 hours and given clear return precautions.

HbA1c 8.1% indicates suboptimal glycemic control, which impairs healing and increases infection risk; coordinate with his physician to optimize glucose control and consider checking a fingerstick glucose at the visit. Renal impairment (CrCl 52 mL/min) affects drug selection:

• Avoid nephrotoxic or renally cleared drugs where possible. Amoxicillin-clavulanate is generally acceptable at this CrCl but dose adjustment may be needed for severe impairment.
• Metronidazole can be added for anaerobic coverage; no major renal dose adjustment for moderate impairment, but watch for neuropathy and disulfiram-like reactions.
• Avoid NSAIDs because of renal impairment and possible interaction with anticoagulation; use acetaminophen instead.
• If opioids are needed, use the lowest effective dose and monitor for sedation; avoid codeine if CYP2D6 ultrarapid metabolism is a concern.
• Clindamycin is an alternative for penicillin allergy but carries a C. difficile risk; not first-line here.

Reassess the need for antibiotics after source control; prolonged courses are not indicated once drainage is achieved.